1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Anterior Ischemic Optic Neuropathy studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research Excerpts

Excerpt	Relevance	Reference
"This study evaluated the effects of intravitreal injection of fasudil (IVF), a Rho-kinase inhibitor, in cases of recent-onset nonarteritic anterior ischemic optic neuropathy (NAION)."	7.83	Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. ( Ahmadieh, H; Esfandiari, H; Hafezi-Moghadam, A; Jamali, A; Nakao, S; Nourinia, R; Pakravan, M; Sanjari, N; Shah-Heidari, MH; Yaseri, M; Zandi, S, 2016)
"This study evaluated the effects of intravitreal injection of fasudil (IVF), a Rho-kinase inhibitor, in cases of recent-onset nonarteritic anterior ischemic optic neuropathy (NAION)."	3.83	Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. ( Ahmadieh, H; Esfandiari, H; Hafezi-Moghadam, A; Jamali, A; Nakao, S; Nourinia, R; Pakravan, M; Sanjari, N; Shah-Heidari, MH; Yaseri, M; Zandi, S, 2016)

Research

Studies (1)

Authors

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Anterior Ischemic Optic Neuropathy

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors	Studies
Sanjari, N	1
Pakravan, M	1
Nourinia, R	1
Esfandiari, H	1
Hafezi-Moghadam, A	1
Zandi, S	1
Nakao, S	1
Shah-Heidari, MH	1
Jamali, A	1
Yaseri, M	1
Ahmadieh, H	1